Gain-of-function mutations of platelet-derived growth factor receptor α gene in gastrointestinal stromal tumors

2003/08/29 by Seiichi Hirota, Akiko Ohashi, Toshirou Nishida +4 · 26 citations
Medicine · #Gastrointestinal Tumor Research and Treatment #Gastrointestinal Bleeding Diagnosis and Treatment #Platelet Disorders and Treatments

paper · doi:10.1016/s0016-5085(03)01046-1

Citations

• KIT Extracellular and Kinase Domain Mutations in Gastrointestinal Stromal Tumors

Cited by

• Role of platelet-derived growth factors in physiology and medicine
• Overexpression of platelet-derived growth factor receptor alpha in breast cancer is associated with tumour progression. [europepmc]
• Neurofibromatosis type 1-related gastrointestinal stromal tumors: a special reference to loss of heterozygosity at 14q and 22q. [europepmc]
• Increased PDGFRalpha activation disrupts connective tissue development and drives systemic fibrosis. [europepmc]
• Molecular target modulation, imaging, and clinical evaluation of gastrointestinal stromal tumor patients treated with sunitinib malate after imatinib failure. [europepmc]
• Amplification of chromosomal segment 4q12 in non-small cell lung cancer. [europepmc]
• Soft tissue sarcoma clinical practice guidelines in oncology. [europepmc]
• NCCN Task Force report: update on the management of patients with gastrointestinal stromal tumors. [europepmc]
• Adjuvant and neoadjuvant imatinib therapy: current role in the management of gastrointestinal stromal tumors. [europepmc]
• Platelet-derived growth factor receptor α-positive cells in the tunica muscularis of human colon. [europepmc]
• Succinate dehydrogenase deficiency in pediatric and adult gastrointestinal stromal tumors. [europepmc]
• A reactive oxygen species-mediated, self-perpetuating loop persistently activates platelet-derived growth factor receptor α. [europepmc]
• Risk factors for gastrointestinal stromal tumor recurrence in patients treated with adjuvant imatinib. [europepmc]
• Gastrointestinal stromal tumors: who should get imatinib and for how long? [europepmc]
• Crosstalk between KIT and FGFR3 Promotes Gastrointestinal Stromal Tumor Cell Growth and Drug Resistance. [europepmc]
• Molecular profiles of high-grade and low-grade pseudomyxoma peritonei. [europepmc]
• Gastrointestinal stromal tumors in Japanese patients with neurofibromatosis type I. [europepmc]
• Advances and Challenges on Management of Gastrointestinal Stromal Tumors. [europepmc]
• Neomorphic PDGFRA extracellular domain driver mutations are resistant to PDGFRA targeted therapies. [europepmc]
• Receptor Tyrosine Kinase-Targeted Cancer Therapy. [europepmc]
• Clinical Diagnosis of Gastrointestinal Stromal Tumor (GIST): From the Molecular Genetic Point of View. [europepmc]
• The Differences in the Proteome Profile of Cannabidiol-Treated Skin Fibroblasts following UVA or UVB Irradiation in 2D and 3D Cell Cultures. [europepmc]
• Tissue-Resident PDGFRα + Progenitor Cells Contribute to Fibrosis versus Healing in a Context- and Spatiotemporally Dependent Manner. [europepmc]
• Avapritinib in unresectable or metastatic PDGFRA D842V-mutant gastrointestinal stromal tumours: Long-term efficacy and safety data from the NAVIGATOR phase I trial. [europepmc]
• Gastrointestinal Stromal Tumors-A Mini Review. [europepmc]
• NCCN Guidelines® Insights: Gastrointestinal Stromal Tumors, Version 2.2022. [europepmc]